Phesi has published its latest annual analysis of global clinical development activity, based on...
NEWS
Bayer receives Breakthrough Therapy Designation for sevabertinib...
Bayer has received Breakthrough Therapy Designation in the United States and China for sevabertinib...
Alnylam to invest $250 million in enzymatic ligation platform to...
Alnylam Pharmaceuticals has announced a $250 million investment to expand its US manufacturing...
Lilly Phase 3 trial shows oral GLP-1 maintains weight loss after...
Eli Lilly has reported Phase 3 results showing that its investigational oral GLP-1 therapy...